Strides Shasun receives USFDA approval for Cyproheptadine Hydrochloride
Strides Shasun has received USFAD approval for Cyproheptadine Hydrochloride tablets, used to relieve such as watery eyes, runny nose, sneezing, hives, and itching. The drug […]
Shasun
Strides Shasun receives USFDA approval for cetrizine hydrochloride
Strides Shasun has received final USFDA approval for cetirizine hydrochloride capsules, used to relieve allergy symptoms. The drug cetirizine hydrochloride will be made available in […]
Strides Shasun receives USFDA approval for memantine hydrochloride tablets
Strides Shasun today has received final USFDA approval for memantine hydrochloride tablets used in the treatment of dementia. The product will be manufactured at the […]
Strides Shasun to expand its Kudikadu plant
Strides Shasun is planning to expand its pharmaceutical plant in Kudikadu in SIPCOT in Cuddalore district of Tamil Nadu. The project involves expanding the manufacturing […]
Strides Shasun receives USFDA approval for Ranitidine
Strides Shasun has received USFDA approval for Ranitidine tablets. The drug Ranitidine is used to treat ulcers of the stomach and intestines and to prevent […]
Strides Shasun acquires Generic Partners Holdings
Strides Shasun has completed acquisition of a controlling stake in Australia-based Generic Partners Holdings. The company has acquired 51 per cent stake in Australia’s Generic […]